跳至主要内容
临床试验/NCT05760469
NCT05760469Unknown不适用

Seeing Red: Towards Improving 'Recognition, Documentation and Outcome 'Measurement of Incontinence-associated 'Dermatitis and Intertrigo

Scotiaderm0 个研究点目标入组 20 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
主要终点
ITD-IAD-M Assessment tool

研究概览

简要总结

This research aims to assess the utility and validate the inter-rater reliability of the new nursing documentation tools for commonly encountered moisture-associated skin damage including (incontinence-associated dermatitis (IAD) and intertrigo (ITD)) at Valley Regional Hospital.

This is an exploratory study to assess the utility and accuracy of a structured documentation tool for IAD and ITD in hospitals. Current documentation involves a mostly verbal description of the location, size, and general features of the rash. Without a standardized approach to documentation, it can be challenging to accurately evaluate the evolution of the rash and the response to treatment from day to day and from different nurses. The reliability of the documentation tool will be assessed by comparing the results of the bedside assessment tool with that completed by wound care experts using standardized digital live photographs. The utility documentation tool from a nursing perspective will also be assessed using a structured questionnaire. Analysis of digital live photographs using a standard algorithm will be done to determine whether such an analysis can objectively and accurately track the healing of moisture-associated skin damage.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • Intertrigo (ITD) and or incontinence-associated dermatitis (IAD)
  • Expected length of stay of seven (7) days
  • life expectancy greater than one week
  • written informed consent by the patient or his/her representative including explicit consent to take daily photographs of the rash associated with MASD.

排除标准

  • known allergy to standard MASD treatments
  • life expectancy less than seven days
  • complex skin disorders

结局指标

主要结局

ITD-IAD-M Assessment tool

时间窗: 7 days

The primary outcome measurement is the correlation between the assessment of the rash by the primary care nurse and the assessment by the wound care expert, with respect to the categorization of the rash, the surface area involvement, and the timing of termination of treatment.

次要结局

未报告次要终点

研究者

发起方
Scotiaderm
申办方类型
Other
责任方
Sponsor

相似试验

Seeing Red: Clinical Assessment Tools for Clinical... | 临床试验